Sumitomo Mitsui Trust Holdings, Inc. Vaxcyte, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $142 Billion
- Q3 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 5,649 shares of PCVX stock, worth $493,101. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,649
Previous 4,529
24.73%
Holding current value
$493,101
Previous $341,000
88.86%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PCVX
# of Institutions
355Shares Held
122MCall Options Held
775KPut Options Held
433K-
Vanguard Group Inc Valley Forge, PA11.4MShares$999 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$953 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$868 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$758 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$428 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.18B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...